A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses
CONCLUSIONS: Our pyrimidine metabolism-centered prognostic signature accurately predicts overall survival, immune status, and treatment response in hepatocellular carcinoma (HCC) patients, offering innovative insights for precise diagnosis, personalized treatment, and improved prognosis.PMID:38517376 | DOI:10.18632/aging.205663
Source: Aging - Category: Biomedical Science Authors: Shihang Zhang Ouyang Qin Shu Wu Huanming Xu Wei Huang Song Hailiang Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Genetics | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Study | Urology & Nephrology